左心室瘢痕与慢性恰加斯心肌病预后
这项前瞻性队列纳入140例慢性恰加斯心肌病患者,用心脏磁共振延迟钆增强评估瘢痕,中位随访34个月。瘢痕阳性者占71.4%,其主要终点和次要终点事件率均高于无瘢痕者;多因素分析显示年龄和LGE面积与主要终点相关。
要点
- 慢性恰加斯心肌病患者中LGE瘢痕常见,占71.4%。
- 瘢痕阳性者主要终点和次要终点事件率均更高。
- 年龄和LGE面积与主要终点独立相关。
核心结论
- 在慢性恰加斯心肌病患者中,LGE提示的瘢痕常见,并与主要不良结局强烈相关。
研究设计与样本
- 前瞻性队列研究,纳入140例慢性恰加斯心肌病患者,52.1%为女性,中位年龄57岁(四分位距45至67岁)。
- 入组时用1.5-T扫描仪行心脏磁共振电影和LGE成像,中位随访34个月(四分位距24至49个月)。
主要发现
- 随访期间记录到11例心血管死亡、3次持续性室性心动过速和20次心血管住院。
- LGE瘢痕存在于71.4%的患者,最常累及侧壁、下侧壁和下壁。
- LGE阳性者左心室射血分数更低,左心室舒张末期容积和质量更高。
- 瘢痕阳性者主要终点事件率更高(p=0.043),次要终点事件率也更高(p=0.016)。
- 多因素分析中,年龄和LGE面积与主要终点相关,年龄和较低左心室射血分数与次要终点相关。
临床怎么用
- 在慢性恰加斯心肌病患者中,可用LGE评估瘢痕以辅助风险分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with chronic Chagas cardiomyopathy (CCC) have pronounced myocardial fibrosis, which may predispose to sudden cardiac death, despite well-preserved global left ventricular (LV) systolic function. Cardiac magnetic resonance can assess myocardial fibrosis by late gadolinium enhancement (LGE) sequences. OBJECTIVES: This prospective study evaluated if the presence of scar by LGE predicted hard adverse outcomes in a cohort of patients with CCC. METHODS: A prospective cohort of 140 patients with CCC (52.1% female; median age 57 years [interquartile range: 45 to 67 years]) were included. Cardiac magnetic resonance cine and LGE imaging were performed at enrollment with a 1.5-T scanner. The primary endpoint was the combination of cardiovascular death and sustained ventricular tachycardia. The secondary endpoint was the combination of cardiovascular death, sustained ventricular tachycardia, or cardiovascular hospitalization during follow-up. RESULTS: After a median of 34 months (interquartile range: 24 to 49 months) of follow-up, 11 cardiovascular deaths, 3 episodes of sustained ventricular tachycardia, and 20 cardiovascular hospitalizations were recorded. LGE scar was present in 71.4% of the patients, with the lateral, inferolateral, and inferior walls most commonly affected. Patients with positive LGE had lower LV ejection fraction and higher LV end-diastolic volume and LV mass than patients without LGE. No difference in other cardiovascular risk factors was noted. Patients with scar had higher event rates compared with those without scar for the primary (p = 0.043) and the secondary (p = 0.016) endpoint. In multivariable analysis, age and LGE area were related to primary outcome; age and lower LV ejection fraction were related to the secondary outcome. The pattern of LGE myocardial fibrosis was transmural, focal, or diffuse scar in approximately one-third of patients with positive LGE, and no pattern was specifically related to outcomes. CONCLUSIONS: In patients with CCC, presence of scar by LGE is common and is strongly associated with major adverse outcomes.
引用
- Volpe GJ, Moreira HT, Trad HS, et al. Left Ventricular Scar and Prognosis in Chronic Chagas Cardiomyopathy. J Am Coll Cardiol. 2018. PMID: 30466514. doi:10.1016/j.jacc.2018.09.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。